RxDoctor Payments Data

Melissa Gelsomino, APRN

Psychiatric/Mental Health · Mineral Ridge, OHNPI 1487264313

Payments from drug & device makers

$6,018in general payments, 2019–2025

Across 340 payments — averaging $17.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alkermes, Inc.$1K
  • Neuronetics, Inc.$683
  • Axsome Therapeutics, Inc.$626
  • AbbVie$558
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$393
  • Lundbeck LLC$358
  • plus $2K from 24 others

What the payments were for

  • Travel & lodging$3626%
  • Food & beverage$5,60793%
  • Education$491%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,018 in reported general payments places this provider in the 90th percentile of 1,808 psychiatric/mental health providers in Ohio.

See all psychiatric/mental health providers in Ohio

Medicare billing

Part B allowed, 2024
$101,162
Medicare patients
167
Services billed
1,028

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
AuvelityDextromethorphan Hbr/Bupropion11$10,496
Venlafaxine Hcl162$3,619
Divalproex Sodium25$1,567
Quetiapine Fumarate82$1,214
Desvenlafaxine Succinate ErDesvenlafaxine Succinate28$1,036
Clozapine11$934
Hydroxyzine Hcl21$768
Amitriptyline Hcl17$517
Venlafaxine Hcl ErVenlafaxine Hcl28$512
Quetiapine Fumarate ErQuetiapine Fumarate15$466
Alprazolam74$437
Sertraline Hcl50$425
Buspirone Hcl19$368
Mirtazapine20$336
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine27$327

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Axsome Therapeutics, Inc.Auvelity$626$10,49611 claims
Almatica Pharma LLCSertraline Hcl$168$42550 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,808 psychiatric/mental health providers in Ohio.

Other psychiatric/mental health in Mineral Ridge

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →